4.39

0.82% 0.0355

After Hours: 4.39

Nexalin Technology Inc (NXL)

Overview News Price History Financials Discussions Forecast

Nexalin Technology Inc stock is traded at $4.39, with a volume of 2,160. It is up +0.82% in the last 24 hours and up +1,277% over the past month. Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Previous Close:

$4.3545

Open:

$4.39

24h Volume:

2,160

Relative Volume:

0.01

Market Cap:

$3.64M

Revenue:

$275.60K

Net Income/Loss:

$-8.33M

P/E Ratio:

-9.5042

EPS:

-0.4619

Net Cash Flow:

$-5.40M

1W Performance:

-10.41%

1M Performance:

+1,277%

6M Performance:

+1,008%

1Y Performance:

+358.10%

1-Day Range:

$4.39

1-Week Range:

$4.00

$5.143

52-Week Range:

$0.2201

$7.69

Nexalin Technology Inc Stock (NXL) Company Profile

Name

Nexalin Technology Inc

Sector

Healthcare (1067)

Industry

Medical Devices (139)

Phone

(832) 260-0222

Address

1776 YORKTOWN, HOUSTON

Employee

Twitter

Next Earnings Date

2026-11-13

Latest SEC Filings

NXL's Discussions on Twitter

Compare NXL vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NXL Nexalin Technology Inc	4.39	3.64M	275.60K	-8.33M	-5.40M	-0.4619
ABT Abbott Laboratories	101.29	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	88.64	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	272.36	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.92	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.29	49.74B	6.30B	1.07B	1.09B	1.8406

Nexalin Technology Inc Stock (NXL) Latest News

Sep 19, 2026

NXL Should I Buy - Intellectia AI

Sep 19, 2026

Sep 18, 2026

Nexalin Technology Inc. (NASDAQ: NXL) Share Price, NXL Stock News, NXL Share Price & Updates - kalkine.com.au

Sep 18, 2026

Sep 11, 2026

Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - ACCESS Newswire

Sep 11, 2026

Sep 10, 2026

Nexalin Technology (NXL) Slips 3.94% to $4.85 as Shares Drift Toward Lower SupportGolden Cross - dars.gov.et

Sep 10, 2026

Sep 08, 2026

Nexalin Technology (NXL) Declines 5.34% to $4.79, Pressuring Key Support LevelSupply Zone - siam.in

Sep 08, 2026

Sep 06, 2026

Nexalin Technology Announces Key Executive Leadership Departure - TipRanks

Sep 06, 2026

Sep 03, 2026

Nexalin Technology registers to sell 5.75M shares of common stock for holders - TipRanks

Sep 03, 2026

Multi-million-share resale could boost Nexalin (NASDAQ: NXL) share count - Stock Titan

Sep 03, 2026

Greenlight Ventures Discloses Investment at Nexalin Technology with 5.6% Stake - TradingView

Sep 03, 2026

Stock-for-deal investor steps in at Nexalin (NASDAQ: NXL) - Stock Titan

Sep 03, 2026

Nexalin Technology (NASDAQ: NXL) Announces Carolyn Shelton's Exit with $20,000 Bonus and Accelerated Stock Option Vesting - kalkinemedia.com

Sep 03, 2026

Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to - Yahoo Finance

Sep 03, 2026

Nexalin Technology Announces New Secondary Analysis of - GlobeNewswire

Sep 03, 2026

Sep 02, 2026

Carolyn Shelton exits Nexalin as Senior VP; separation terms include bonus and option vesting - TradingView

Sep 02, 2026

Nexalin Technology, Inc. Announces Resignation of Carolyn Shelton from Senior Vice President of Quality, Regulatory, and Clinical Affairs, Effective August 28, 2026 - marketscreener.com

Sep 02, 2026

Sep 01, 2026

Alumni Capital LP Holds 9.99% Stake in Nexalin Technology (NASDAQ: NXL), Disclosing 2.49 Million Shares - Kalkine Media

Sep 01, 2026

Aug 28, 2026

Nexalin Announces 1-for-30 Reverse Stock Split Approval - The Globe and Mail

Aug 28, 2026

Aug 27, 2026

Nexalin Technology approves 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria

Aug 27, 2026

Nexalin Technology (NXL) draws new near-10% investor stake - Stock Titan

Aug 27, 2026

Aug 22, 2026

Nexalin (NXL) Levels: Ends Higher by 0.45% at $0.33 in the Latest Reading - careplusvn.com

Aug 22, 2026

Aug 21, 2026

Nexalin Technology Raises Liquidity via Short-Term Note - TipRanks

Aug 21, 2026

Nexalin Technology Issues $1.17 Million OID Note for $1.0 Million Proceeds - TradingView

Aug 21, 2026

Aug 20, 2026

Nexalin Announces Capital Raise and Flexible Equity Facility - TipRanks

Aug 20, 2026

Nexalin Technology Raises $750,000 in Registered Direct Offering - minichart.com.sg

Aug 20, 2026

Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital - TradingView

Aug 20, 2026

Aug 19, 2026

Nexalin (NXL) EPS and Revenue: EPS Does Not Reach the Reported Estimate in the Available Record; The Share Price Sheds 2.06% in Latest TradingEPS Guidance Update - dars.gov.et

Aug 19, 2026

Aug 18, 2026

Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - The Globe and Mail

Aug 18, 2026

Aug 17, 2026

Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 17, 2026

Aug 16, 2026

Nexalin Technology earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa

Aug 16, 2026